|
1
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B, Senn HJ, Albain KS, André F,
Bergh J, et al: Panel members: Personalizing the treatment of women
with early breast cancer: Highlights of the St Gallen International
Expert Consensus on the Primary Therapy of Early Breast Cancer
2013. Ann Oncol. 24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coates AS, Winer EP, Goldhirsch A, Gelber
RD, Gnant M, Piccart-Gebhart M, Thürlimann B and Senn HJ: Panel
Members: Tailoring therapies - improving the management of early
breast cancer: St Gallen International Expert Consensus on the
Primary Therapy of Early Breast Cancer 2015. Ann Oncol.
26:1533–1546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mohammed ZM, McMillan DC, Edwards J,
Mallon E, Doughty JC, Orange C and Going JJ: The relationship
between lymphovascular invasion and angiogenesis, hormone
receptors, cell proliferation and survival in patients with primary
operable invasive ductal breast cancer. BMC Clin Pathol. 13:312013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mok SC, Bonome T, Vathipadiekal V, Bell A,
Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, et al: A
gene signature predictive for outcome in advanced ovarian cancer
identifies a survival factor: Microfibril-associated glycoprotein
2. Cancer Cell. 16:521–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bowen NJ, Walker LD, Matyunina LV, Logani
S, Totten KA, Benigno BB and McDonald JF: Gene expression profiling
supports the hypothesis that human ovarian surface epithelia are
multipotent and capable of serving as ovarian cancer initiating
cells. BMC Med Genomics. 2:712009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Elgaaen Vilming B, Olstad OK, Haug KB,
Brusletto B, Sandvik L, Staff AC, Gautvik KM and Davidson B: Global
miRNA expression analysis of serous and clear cell ovarian
carcinomas identifies differentially expressed miRNAs including
miR-200c-3p as a prognostic marker. BMC Cancer. 14:802014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elgaaen BV, Olstad OK, Sandvik L, Odegaard
E, Sauer T, Staff AC and Gautvik KM: ZNF385B and VEGFA are strongly
differentially expressed in serous ovarian carcinomas and correlate
with survival. PLoS One. 7:e463172012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong W, He L, Richards EJ, Challa S, Xu
CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY, et
al: Upregulation of miRNA-155 promotes tumour angiogenesis by
targeting VHL and is associated with poor prognosis and
triple-negative breast cancer. Oncogene. 33:679–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ward A, Shukla K, Balwierz A, Soons Z,
König R, Sahin O and Wiemann S: MicroRNA-519a is a novel oncomir
conferring tamoxifen resistance by targeting a network of
tumour-suppressor genes in ER+ breast cancer. J Pathol.
233:368–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasheed SA, Teo CR, Beillard EJ, Voorhoeve
PM, Zhou W, Ghosh S and Casey PJ: MicroRNA-31 controls G protein
alpha-13 (GNA13) expression and cell invasion in breast cancer
cells. Mol Cancer. 14:672015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Planche A, Bacac M, Provero P, Fusco C,
Delorenzi M, Stehle JC and Stamenkovic I: Identification of
prognostic molecular features in the reactive stroma of human
breast and prostate cancer. PLoS One. 6:e186402011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clarke C, Madden SF, Doolan P, Aherne ST,
Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown
J, et al: Correlating transcriptional networks to breast cancer
survival: A large-scale coexpression analysis. Carcinogenesis.
34:2300–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wasson MK, Chauhan PS, Singh LC, Katara D,
Sharma Dev J, Zomawia E, Kataki A, Kapur S and Saxena S:
Association of DNA repair and cell cycle gene variations with
breast cancer risk in Northeast Indian population: A multiple
interaction analysis. Tumour Biol. 35:5885–5894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romero-Cordoba S, Rodriguez-Cuevas S,
Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez
G, Bautista-Piña V, Arellano-Llamas R and Hidalgo-Miranda A:
Identification and pathway analysis of microRNAs with no previous
involvement in breast cancer. PLoS One. 7:e319042012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets - update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Radojicic J, Zaravinos A, Vrekoussis T,
Kafousi M, Spandidos DA and Stathopoulos EN: MicroRNA expression
analysis in triple-negative (ER, PR and Her2/neu) breast cancer.
Cell Cycle. 10:507–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi W, Gerster K, Alajez NM, Tsang J,
Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, et al:
MicroRNA-301 mediates proliferation and invasion in human breast
cancer. Cancer Res. 71:2926–2937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayashi M, Nomoto S, Kanda M, Okamura Y,
Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S and Kodera Y:
Identification of the A kinase anchor protein 12 (AKAP12) gene as a
candidate tumor suppressor of hepatocellular carcinoma. J Surg
Oncol. 105:381–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Flotho C, Paulun A, Batz C and Niemeyer
CM: AKAP12, a gene with tumour suppressor properties, is a target
of promoter DNA methylation in childhood myeloid malignancies. Br J
Haematol. 138:644–650. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su B, Zheng Q, Vaughan MM, Bu Y and Gelman
IH: SSeCKS metastasis-suppressing activity in MatLyLu prostate
cancer cells correlates with vascular endothelial growth factor
inhibition. Cancer Res. 66:5599–5607. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi MC, Jong HS, Kim TY, Song SH, Lee DS,
Lee JW, Kim TY, Kim NK and Bang YJ: AKAP12/Gravin is inactivated by
epigenetic mechanism in human gastric carcinoma and shows growth
suppressor activity. Oncogene. 23:7095–7103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goeppert B, Schmezer P, Dutruel C, Oakes
C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi
A, et al: Down-regulation of tumor suppressor A kinase anchor
protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Hepatology. 52:2023–2033. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia W, Ni J, Zhuang J, Qian L, Wang P and
Wang J: MiR-103 regulates hepatocellular carcinoma growth by
targeting AKAP12. Int J Biochem Cell Biol. 71:1–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruan HH, Li Y, Zhang XX, Liu Q, Ren H,
Zhang KS and Zhao H: Identification of TRAF6 as a ubiquitin ligase
engaged in the ubiquitination of SopB, a virulence effector protein
secreted by Salmonella typhimurium. Biochem Biophys Res
Commun. 447:172–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perrett CA and Zhou D: Erratum:
Salmonella type III effector SopB modulates host cell
exocytosis. Emerg Microbes Infect. 2:e392013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tahoun A, Mahajan S, Paxton E, Malterer G,
Donaldson DS, Wang D, Tan A, Gillespie TL, O'Shea M, Roe AJ, et al:
Salmonella transforms follicle-associated epithelial cells
into M cells to promote intestinal invasion. Cell Host Microbe.
12:645–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ravindranath A, O'Connell A, Johnston PG
and El-Tanani MK: The role of LEF/TCF factors in neoplastic
transformation. Curr Mol Med. 8:38–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Connor AE, Baumgartner RN, Baumgartner KB,
Kerber RA, Pinkston C, John EM, Torres-Mejia G, Hines L, Giuliano
A, Wolff RK, et al: Associations between TCF7L2 polymorphisms and
risk of breast cancer among Hispanic and non-Hispanic white women:
The Breast Cancer Health Disparities Study. Breast Cancer Res
Treat. 136:593–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu XP, Hu GN, Du JQ and Li HQ: TCF7L2 gene
polymorphisms and susceptibility to breast cancer: A meta-analysis.
Genet Mol Res. 14:2860–2867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naidu R, Yip CH and Taib NA: Genetic
variations in transcription factor 7-like 2 (TCF7L2) gene:
Association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast
cancer risk and clinico-pathological parameters. Med Oncol.
29:411–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Min W, Liu X, Lu Y, Gong Z, Wang M, Lin S,
Kang H, Jin T, Wang X, Ma X, et al: Association of transcription
factor 7-like 2 gene polymorphisms with breast cancer risk in
northwest Chinese women. Oncotarget. 7:77175–77182. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lan F, Yue X, Han L, Shi Z, Yang Y, Pu P,
Yao Z and Kang C: Genome-wide identification of TCF7L2/TCF4 target
miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer.
Int J Oncol. 40:519–526. 2012.PubMed/NCBI
|
|
40
|
Wang X and Xia Y: microRNA-328 inhibits
cervical cancer cell proliferation and tumorigenesis by targeting
TCF7L2. Biochem Biophys Res Commun. 475:169–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou C, Tan DM, Chen L, Xu XY, Sun CC,
Zong LJ, Han S and Zhang YZ: Effect of miR-212 targeting TCF7L2 on
the proliferation and metastasis of cervical cancer. Eur Rev Med
Pharmacol Sci. 21:219–226. 2017.PubMed/NCBI
|
|
42
|
Ouyang D, Xu L, Zhang L, Guo D, Tan X, Yu
X, Qi J, Ye Y, Liu Q, Ma Y, et al: MiR-181a-5p regulates 3T3-L1
cell adipogenesis by targeting Smad7 and Tcf7l2. Acta Biochim
Biophys Sin (Shanghai). 48:1034–1041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim SY, Suh HW, Chung JW, Yoon SR and Choi
I: Diverse functions of VDUP1 in cell proliferation,
differentiation, and diseases. Cell Mol Immunol. 4:345–351.
2007.PubMed/NCBI
|
|
44
|
Zhou J, Yu Q and Chng WJ: TXNIP (VDUP-1,
TBP-2): A major redox regulator commonly suppressed in cancer by
epigenetic mechanisms. Int J Biochem Cell Biol. 43:1668–1673. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cadenas C, Franckenstein D, Schmidt M,
Gehrmann M, Hermes M, Geppert B, Schormann W, Maccoux LJ, Schug M,
Schumann A, et al: Role of thioredoxin reductase 1 and thioredoxin
interacting protein in prognosis of breast cancer. Breast Cancer
Res. 12:R442010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou J and Chng WJ: Roles of thioredoxin
binding protein (TXNIP) in oxidative stress, apoptosis and cancer.
Mitochondrion. 13:163–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nie W, Huang W, Zhang W, Xu J, Song W,
Wang Y, Zhu A, Luo J, Huang G, Wang Y, et al: TXNIP interaction
with the Her-1/2 pathway contributes to overall survival in breast
cancer. Oncotarget. 6:3003–3012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cittelly DM, Das PM, Spoelstra NS,
Edgerton SM, Richer JK, Thor AD and Jones FE: Downregulation of
miR-342 is associated with tamoxifen resistant breast tumors. Mol
Cancer. 9:3172010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhu HJ, Wang DG, Yan J and Xu J:
Up-regulation of microRNA-135a protects against myocardial
ischemia/reperfusion injury by decreasing TXNIP expression in
diabetic mice. Am J Transl Res. 7:2661–2671. 2015.PubMed/NCBI
|
|
50
|
Li XF, Shen WW, Sun YY, Li WX, Sun ZH, Liu
YH, Zhang L, Huang C, Meng XM and Li J: MicroRNA-20a negatively
regulates expression of NLRP3-inflammasome by targeting TXNIP in
adjuvant-induced arthritis fibroblast-like synoviocytes. Joint Bone
Spine. 83:695–700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen D, Dang BL, Huang JZ, Chen M, Wu D,
Xu ML, Li R and Yan GR: MiR-373 drives the
epithelial-to-mesenchymal transition and metastasis via the
miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Oncotarget. 6:32701–32712. 2015.PubMed/NCBI
|
|
52
|
Wang JG, Zhang LK, Chen YB, Zhang T, Yuan
PF and Liu DC: Influence of miR-373 on the invasion and migration
of breast cancer and the expression level of target genes TXNIP. J
Biol Regul Homeost Agents. 29:367–372. 2015.PubMed/NCBI
|
